Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Cycles Fertility App Wins FDA Clearance For Oura Ring Integration

Executive Summary

The app, the first to be approved with a birth control indication, can now sync data directly from the Oura Ring, a wearable device that tracks user’s biometrics.

You may also be interested in...



Oura Debuts New Stress Analyzers, Partnership With Headspace

At HLTH, Oura debuted stress-focused features aimed to help wearers identify stress triggers, reduce stress, as well as a new AI-powered tool that allows its members digital journaling. Oura’s new partnership with the mindfulness app maker Headspace, lets users access stress-relieving content, such as meditations.

Oura Debuts New Stress Analyzers, Partnership With Headspace At HLTH

At HLTH, Oura debuted stress-focused features aimed to help wearers identify stress triggers, reduce stress, as well as a new AI-powered tool that allows its members digital journaling. Oura’s new partnership with the mindfulness app maker Headspace, lets users access stress-relieving content, such as meditations.

Period-Tracking Apps Should Safeguard Data, Reassure Customers In Post-Roe Era

Nixon Gwilt Law attorney Bethany Corbin spoke with Medtech Insight about key action steps developers of period-tracking apps can take to ensure that sensitive health data remain safe and private.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel